# A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea

> **NCT04713826** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 93 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** BAY2586116
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04713826
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-03
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-11-11
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713826, "A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04713826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*